The first two volunteers, one control (meningitis vaccine) and the other the vaccine treatment, were injected on April 23, 2020 for the Oxford University Phase I human vaccine clinical trials. [1]

The Oxford researchers started screening healthy volunteers (aged 18-55) in March 2020 for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region.

Seven days later on April 30, 2020 Oxford University announces partnership with AstraZeneca to help develop and distribute their COVID-19 vaccine.

On April 24, 2020 at a virtual event co-hosted by the World Health Organization (Tedros), the President of France (Emmanuel Macron), the President of the European Commission (Ursula Von Der Leyen), and the Bill & Melinda Gates Foundation, leaders of global health organisations (including Big Pharma) came together to “ensure” that “everyone everywhere” can have access to “new vaccines, tests and treatments for COVID-19”.  Especially the brand new technology COVID-19 vaccines, pushing them through an unprecedented, accelerated development and production process.  [1, 2, 3]

They called on the global community and political leaders to support their “landmark collaboration” asking for financial support to accelerate their objectives and capitalize on the “opportunity”, by attending a May 4, 2020 virtual pledging initiative.

This meeting launched the WHO Access to COVID-19 Tools Accelerator (ACT Accelerator) which “brings together the combined power of several organizations to work with speed and scale”.  The “tools” comprise vaccines, tests and treatments.

• By August 2020, COVAX will became the vaccine arm of the ACT Accelerator initiative [4, 5]

On April 24, 2020 the World Health Organisation released a Scientific Brief that warned “[t]here is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection.”  This comes just as antibody testing kicks off in the US and as some “governments have suggested that the detection of antibodies to the SARS-CoV-2…could serve as the basis for an “immunity passport” or “risk-free certificate” that would enable individuals to travel or to return to work assuming that they are protected against re-infection.”[1, 2, 3]

A few days before it was reprted that “Michael Ryan, executive director of the World Health Organization’s Emergencies Program was asked how long a recovered COVID-19 patient would have immunity, he said, “We do not have the answers to that — it’s an unknown,” and added, “We would expect that to be a reasonable period of protection, but it is very difficult to say with a new virus — we can only extrapolate from other coronaviruses, and even that data is quite limited.””

By April 25, 2020 many studies [1] and data observations revealed that SARS-CoV-2 infections amongst the US population was much higher than estimated. Many people tested PCR positive but had no symptoms.

The late 2019 “flu season” in the US was high in incidence and many tests came back negative for influenza. Is it possible SARS-CoV-2 was already circulating in the US population in late 2019, and the positive PCR’s were the result of high test amplifications greater than 35 cycles which were just picking up “dead nucleotides“, possibly left from a recent past infection?

On April 27, 2020 a paper published by French Doctor Didier Raoult et al, showed that a PCR test resulting from amplifying 34 cycles or more does not have viable virus, meaning the person is not infectious and the test is a false positive.

The paper determined:

• SARS-CoV-2 RNA positivity in patient samples was assessed by real-time reverse transcription-PCR [RT-PCR] targeting the E gene.
• We observed a significant relationship between Ct value and culture positivity rate
• No culture was obtained from samples with Ct > 34
• Our results show that in our system of RT-PCR, we can assess that patients with Ct equal or above 34 may be discharged.

Patients were only told it they were positive or negative, the lab did not report the Ct value.  PCR tests had a cycle threshold of 40-45, meaning they did not cut off the cycling until that point, which resulted in many “false positves” COVID-19 “cases”. [1]

On April 30, 2020 a pre-print paper by Korber et al, (now peer reviewed) had identified 14 mutations in the Spike (S) protein of the SARS-CoV-2 virus. [1, 2]

This is highly consequential as the Spike protein “mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics.” Mutations in this region of the virus “may confer selective advantages in transmission or resistance to interventions”

It was noted that this mutation of “Spike D614G is of urgent concern” They first identified G614 mutation in Italy sample on February 20, 2020 where it “began spreading in Europe” and found “when introduced to new regions it rapidly becomes the dominant form” indicating highly transmissible.

Noteworthy also is they found “evidence of recombination between locally circulating strains” in the S943P mutation, meaning an infected person is infected with multiple virus strains, not just one, and the stains can re-combine their genetic material to form new “recombinant” virus strains.

On May 3, 2020 President John Magufuli of Tanzania said in order to evaluate the quality of imported PCR test kits, the Tanzanian security forces randomly obtained non-human samples, including from a pawpaw, a goat and a sheep and assigned human names. The labs reported the pawpaw and goat as testing positive for COVID-19.  The faulty kits meant some people were testing positive for COVID-19 without actually being infected.  [1, 2]

In late January 2021 President Magufuli rejected the  COVID-19 vaccines, then by mid March dies of “heart condition” thought to be “mysterious”. [3]

On May 9, 2020 the article titled “Reconnecting for our future: The Lancet One Health Commission” was published by Amuasi et al in The Lancet to officially announce the commissions framworkd.  The commission was formed a year earlier. At the core of the Commission‘s work is the “recognition of several possible approaches to examining the animal–environment–human interface” which they “distill into three distinct but interrelated dimensions” [1, 3, 4]

EcoHealth Alliance‘s (EHA) Peter Daszak, funder of Wuhan Institute of Virology’s coronavirus research is on The Lancet One Health Commission! EHA is stated to be “A leader in the One Health movement which began in 2004” [2]

•  “One Health, One World™” movement traces back to 2004 before the rebranding of EcoHealth Alliance in 2010
• The commission members released in 2021 – One Health as a Pillar for a Transformative Pandemic Treaty – Policy Brief , by Arne Ruckert et al [5], which seems to have began with a Canadian Public Health paper by Ruckert!

The “One Health framework by Amuasi et al (shown in Figure 1) to inform the work of the Lancet Commission on One Health, depicts the systems at this interface in a more connected way. It describes three dimensions of One Health, including the shared environment, food and food systems and interventions and medicines, each of which play a role in either the emergence of or response to zoonotic disease outbreaks.” [6]

On May 14, 2020, what will become known as the People’s Vaccine Alliance (PVA) is started by a press release about open letter signed by more than 140 influences and activists “calling on all governments to unite behind a people’s vaccine against COVID-19”  The “movement” is coordinated by Oxfam and USAIDS.

Humanity today, in all its fragility, is searching for an effective and safe vaccine against COVID-19. It is our best hope of putting a stop to this painful global pandemic….
Only a people’s vaccine — with equality and solidarity at its core — can protect all of humanity and get our societies safely running again. A bold international agreement cannot wait. …In doing so, no one can be left behind – The Letter states

On June 4, 2020 at the Global Vaccine Summit, the United Nations Director General repeated the mantra:

A COVID-19 vaccine must be seen as a global public good, a People’s Vaccine

By September 17, 2020 Oxfam “warns” that a small group of rich nations, representing just 13 percent of the world’s population, have bought up 51%, more than half of the promised doses of leading COVID-19 vaccine candidates, as the health and finance ministers of G20 countries meet the same day to discuss the global pandemic. [3]

Then on September 29, 2020 Oxfam promotes that 242 COVID-19 survivors “from 37 countries are among almost 1,000 people who have signed an open letter to pharmaceutical industry leaders calling for a ‘People’s vaccine’ and treatments that are available to all.” [3]

“People’s Vaccine Alliance is a coalition of organisations and activists united under a common aim of campaigning for a ‘people’s vaccine’ for COVID-19 that is based on shared knowledge and is freely available to everyone everywhere. A global common good. It is coordinated by Oxfam and UNAIDS ” [2]  October 22, 2020 was the first archive of the PVA website.

On May 22, 2020 the CDC released pandemic planning data which reveals that they estimate the fatality rate for COVID-19 at 0.26%.

Here’s how it works.  The CDC data estimates that 35% of coronavirus infections are asymptomatic, and their new “best estimate” for the case fatality rate amongst symptomatic patients is 0.4%, quite a bit different to the WHO’s 3.4% fatality rate estimated on March 4, 2020. [2, 3]

A PJ Media article does the maths: “According to the CDC’s own current best estimate data the case fatality rate (CFR) of the coronavirus is 0.4%. And that’s just amongst symptomatic cases, which, the CDC estimates, is 65% of all cases. This means the CDC estimates the Infection Fatality Rate (IFR), that being the fatality rate for all infections across all age groups, symptomatic as well as asymptomatic, is approximately 0.26%.”

This is the “biggest reason to end the coronavirus lockdowns” and go back to normal.

Swiss Policy Research shows the the global IFR statistics ranges from 0.20% to 0.68%, but in all ages under 70 years of age the fatality estimate is 0.04%.  and compared to the Delta variant, the Omicron variant has a 90% lower death rate.”  Also by Sep 2022 the data shows Australia’s median age of death is 86 yrs and US is 78 years.

In a study published May 22, 2020 by Bullard et al , in Clinical Infectious Diseases, it was found that out of 90 PCR positive samples, there was no viable viral growth in samples with a Cycle Threshold (Ct) > 24. [1]

All tests over Ct of 24 should have been disregarded according to this evidence. The tests can’t tell the difference between active and inactive RNA matter. All laboratories should report the number of cycles they used to return all positive results, to gauge it’s accuracy.

A few weeks after the Bullard study, on June 8, 2020, the Australian government first released their “Public Health Laboratory Network Guidance on Nucleic Acid Test Result Interpretation for SARS-CoV-2”.

By July 13, 2020 they sent out an update “to clarify the terms ‘false positives’ and ‘inconclusive results‘”, where they are fully aware that off-target (non-specific) material could potentially be amplified, and this type of false positive occurs with high Ct.  Though “usually 35-45 cycles are undertaken”, which anything over 40 (according to this guidance) is high!

It states “To comply with TGA requirements, the laboratory must report the results according to the commercial manufacturer’s recommendations.” This means every person who had a PCR test, the lab should have recorded the Ct value,